Rabeprazole sodium and Dapsone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rabeprazole sodium (rabeprazole sodium) and Dapsone (dapsone). Common drug interactions include pneumonia among females and dyspnoea exertional among males.

The phase IV clinical study analyzes what interactions people have when they take Rabeprazole sodium and Dapsone. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Rabeprazole sodium?

Rabeprazole sodium has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 15,786 Rabeprazole sodium users. Check the latest studies of Rabeprazole sodium.

What is Dapsone?

Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 11,732 Dapsone users. Check the latest studies of Dapsone.



On Jul, 10, 2026

23 people who take Rabeprazole sodium and Dapsone together, and have interactions are studied.

Rabeprazole sodium and Dapsone drug interactions.

What are the common drug interactions of Rabeprazole Sodium and Dapsone, by gender? *:

female:

  1. Pneumonia
  2. Renal failure (kidney dysfunction)
  3. Suicidal behaviour
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Aphthous ulcer (mouth ulcer)
  6. Behcet's syndrome (involves inflammation of the blood vessels)
  7. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  8. Arterial disorder
  9. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  10. Fatigue (feeling of tiredness)

male:

  1. Dyspnoea exertional (breathlessness or shortness of breath)
  2. Pneumonia
  3. Fall
  4. Lethargy (tiredness)
  5. Myasthenia gravis crisis (a paralysis of the respiratory muscles occurs)
  6. Poor venous access
  7. Pulmonary function test decreased
  8. Pyrexia (fever)
  9. Respiratory distress (difficulty in breathing)
  10. Skin exfoliation (removal of the oldest dead skin cells)

What are the common drug interactions of Rabeprazole Sodium and Dapsone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)

40-49:

  1. Blood pressure increased
  2. Depression
  3. Hellp syndrome (life-threatening pregnancy complication)
  4. Influenza
  5. Pneumonia
  6. Renal failure (kidney dysfunction)
  7. Suicidal behaviour
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Aphthous ulcer (mouth ulcer)
  10. Behcet's syndrome (involves inflammation of the blood vessels)

50-59:

  1. Hyperglycaemia (high blood sugar)
  2. Hyperlipidaemia (presence of excess lipids in the blood)
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  4. Hypokalaemia (low potassium)
  5. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  6. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  7. Hypotension (abnormally low blood pressure)
  8. Hypovolaemia (a decreased volume of circulating blood in the body)
  9. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  10. Intervertebral disc protrusion (spinal disc protrusion)

60+:

  1. Arthropathy
  2. Asthenia (weakness)
  3. Myasthenia gravis crisis (a paralysis of the respiratory muscles occurs)
  4. Pneumonia
  5. Poor venous access
  6. Pulmonary function test decreased
  7. Pyrexia (fever)
  8. Respiratory distress (difficulty in breathing)
  9. Skin exfoliation (removal of the oldest dead skin cells)
  10. Skin warm

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 13.04%
  2. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 3 people, 13.04%
  3. Canker Sores (painful, open sore in the mouth): 3 people, 13.04%
  4. Behcet's Syndrome (involves inflammation of the blood vessels): 3 people, 13.04%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole sodium and Dapsone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rabeprazole sodium and Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rabeprazole sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rabeprazole sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dapsone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium and dapsone (the active ingredients of Rabeprazole sodium and Dapsone, respectively), and Rabeprazole sodium and Dapsone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: